Intravesical Mitomycin-C with Bladder Wall Hyperthermia in Intermediate and High-risk Non-muscle Invasive Bladder Cancers: Prospective Clinical Trial with a Singletreatment Arm

Journal Title: The Bulletin of Urooncology - Year 2020, Vol 19, Issue 4

Abstract

Objective: Bacillus Calmette-Guérin (BCG) limited availability, cost, and allergic response in some patients limit its use, leading to the search for alternative agents. We aimed to present the outcomes of intermediate- and high-risk non-muscle invasive bladder cancers treated with bladder wall thermochemotherapy (BWT) system via a single-arm prospective study. Materials and Methods: Overall, 44 patients were enrolled and subjected to a treatment with mitomycin-C and BWT for 6 weeks, followed by a monthly maintenance for up to 1 year. The recurrence rate, progression rate, recurrence-free survival, progression-free survival, and side effects were evaluated. Results: In the intermediate- and high-risk groups, the median follow-up duration was 14 and 17 months; recurrence rates were 28.6% and 23.3%; progression rates were 7.1% and 23.3%; the recurrence free survival at the 24th month were 78.6% and 80.0% and the progression free survival at the 24th month were 92.6% and 76.7%, respectively. All the patients suffered from dysuria lasting for 2-3 days; five of the 442 BWT application developed allergic reactions requiring treatments with oral agents. Conclusion: BWT showed comparable recurrence and progression rates, but seemed safer than BCG when our findings were compared to those of published studies. It could be an alternative for individuals who are not suitable for BCG or in a case of BCG unavailability.

Authors and Affiliations

Abdullah Demirtaş, Şevket Tolga Tombul, Gökhan Sönmez, Akın Demirleğen, Türev Demirtaş, Atila Tatlışen

Keywords

Related Articles

The Role of Adrenal Cortex-Sparing Surgery for Bilateral Masses in Three Cases

Pheochromocytoma are the functional adrenal lesions originating from the chromaffin cells. For the cases of pheochromocytoma observed in multiple endocrine neoplasia Type 2 and Von Hippel syndrome, the bilateral adrenal...

Changes in Metastatic Castration Sensitive Prostate Cancer

Prostate cancer is the second most common cancer in men worldwide, with approximately 1,276,106 new patients and 358,989 new deaths. Metastatic castrationsensitive prostate cancer may be de novo metastatic, but also it m...

Robotic Seminal Vesicle Surgery: The Key Steps

Seminal vesicle (SV) cystic masses are rarely encountered entities in daily clinical practice. They are mostly asymptomatic and require no treatment; however, surgical removal of the cyst is highly effective treatment in...

Renal Angiomyolipoma: A Clinicopathological Study of Seven Cases and Review of the Literature

Objective: Renal angiomyolipomas (AMLs) are mesenchymal kidney tumours that have triphasic histology. This study aimed to present the clinical, pathological and immunohistochemical features of seven AML cases along with...

Evaluation of the Risk of Falls in the Patients Hospitalized in A Urology Inpatient Clinic

Objective: Falls are a significant cause of morbidity and mortality, particularly in hospitalized patients. In this study, we aimed to evaluate the risk of falls in the patients hospitalized in a urology clinic. Materia...

Download PDF file
  • EP ID EP691636
  • DOI 10.4274/uob.galenos.2019.1314
  • Views 101
  • Downloads 0

How To Cite

Abdullah Demirtaş, Şevket Tolga Tombul, Gökhan Sönmez, Akın Demirleğen, Türev Demirtaş, Atila Tatlışen (2020). Intravesical Mitomycin-C with Bladder Wall Hyperthermia in Intermediate and High-risk Non-muscle Invasive Bladder Cancers: Prospective Clinical Trial with a Singletreatment Arm. The Bulletin of Urooncology, 19(4), -. https://europub.co.uk/articles/-A-691636